Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis	Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, fatty liver disease, liver disorder, metabolic dysfunction-associated steatotic liver disease	Recruiting	Not applicable	2025-12-08		NCT07270601

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
ContextVision AB	1
University of Washington	397

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Washington	Seattle	United States	172

Clinical trials